DHT HOLDINGS INC (DHT)

MHY2065G1219 - Common Stock

11.13  -0.05 (-0.45%)

Fundamental Rating

6

Overall DHT gets a fundamental rating of 6 out of 10. We evaluated DHT against 209 industry peers in the Oil, Gas & Consumable Fuels industry. DHT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. DHT has a correct valuation and a medium growth rate.



6

1. Profitability

1.1 Basic Checks

In the past year DHT was profitable.
In the past year DHT had a positive cash flow from operations.
Of the past 5 years DHT 4 years were profitable.
In the past 5 years DHT always reported a positive cash flow from operatings.

1.2 Ratios

The Return On Assets of DHT (10.97%) is better than 78.92% of its industry peers.
The Return On Equity of DHT (15.70%) is better than 64.71% of its industry peers.
With a decent Return On Invested Capital value of 10.96%, DHT is doing good in the industry, outperforming 72.06% of the companies in the same industry.
Industry RankSector Rank
ROA 10.97%
ROE 15.7%
ROIC 10.96%
ROA(3y)4.73%
ROA(5y)6.93%
ROE(3y)6.79%
ROE(5y)10.46%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin of DHT (27.72%) is better than 75.00% of its industry peers.
In the last couple of years the Profit Margin of DHT has declined.
With a decent Operating Margin value of 33.26%, DHT is doing good in the industry, outperforming 67.65% of the companies in the same industry.
In the last couple of years the Operating Margin of DHT has grown nicely.
DHT's Gross Margin of 55.55% is fine compared to the rest of the industry. DHT outperforms 61.27% of its industry peers.
DHT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 33.26%
PM (TTM) 27.72%
GM 55.55%
OM growth 3Y-9.97%
OM growth 5Y45.73%
PM growth 3Y-9.27%
PM growth 5YN/A
GM growth 3Y-5.61%
GM growth 5Y9.15%

7

2. Health

2.1 Basic Checks

DHT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for DHT has been reduced compared to 1 year ago.
Compared to 5 years ago, DHT has more shares outstanding
Compared to 1 year ago, DHT has a worse debt to assets ratio.

2.2 Solvency

DHT has an Altman-Z score of 3.17. This indicates that DHT is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.17, DHT is in the better half of the industry, outperforming 76.96% of the companies in the same industry.
The Debt to FCF ratio of DHT is 2.16, which is a good value as it means it would take DHT, 2.16 years of fcf income to pay off all of its debts.
DHT's Debt to FCF ratio of 2.16 is fine compared to the rest of the industry. DHT outperforms 74.02% of its industry peers.
DHT has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
DHT has a Debt to Equity ratio of 0.35. This is comparable to the rest of the industry: DHT outperforms 53.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 2.16
Altman-Z 3.17
ROIC/WACC1.23
WACC8.94%

2.3 Liquidity

DHT has a Current Ratio of 2.41. This indicates that DHT is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of DHT (2.41) is better than 77.45% of its industry peers.
A Quick Ratio of 2.41 indicates that DHT has no problem at all paying its short term obligations.
DHT's Quick ratio of 2.41 is fine compared to the rest of the industry. DHT outperforms 79.41% of its industry peers.
Industry RankSector Rank
Current Ratio 2.41
Quick Ratio 2.41

5

3. Growth

3.1 Past

DHT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.04%.
The earnings per share for DHT have been decreasing by -16.82% on average. This is quite bad
The Revenue has decreased by -0.23% in the past year.
DHT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.32% yearly.
EPS 1Y (TTM)-13.04%
EPS 3Y-16.82%
EPS 5YN/A
EPS Q2Q%15.79%
Revenue 1Y (TTM)-0.23%
Revenue growth 3Y-6.74%
Revenue growth 5Y8.32%
Sales Q2Q%3.99%

3.2 Future

DHT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.22% yearly.
The Revenue is expected to grow by 12.57% on average over the next years. This is quite good.
EPS Next Y1.79%
EPS Next 2Y22.23%
EPS Next 3Y25.53%
EPS Next 5Y25.22%
Revenue Next Year1.68%
Revenue Next 2Y3.34%
Revenue Next 3Y6.05%
Revenue Next 5Y12.57%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.13, which indicates a very decent valuation of DHT.
Compared to the rest of the industry, the Price/Earnings ratio of DHT indicates a somewhat cheap valuation: DHT is cheaper than 61.76% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.28. DHT is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 7.52 indicates a rather cheap valuation of DHT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DHT indicates a somewhat cheap valuation: DHT is cheaper than 77.94% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.53, DHT is valued rather cheaply.
Industry RankSector Rank
PE 11.13
Fwd PE 7.52

4.2 Price Multiples

DHT's Enterprise Value to EBITDA ratio is in line with the industry average.
DHT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DHT is cheaper than 70.59% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.51
EV/EBITDA 6.97

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of DHT may justify a higher PE ratio.
A more expensive valuation may be justified as DHT's earnings are expected to grow with 25.53% in the coming years.
PEG (NY)6.2
PEG (5Y)N/A
EPS Next 2Y22.23%
EPS Next 3Y25.53%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.95%, DHT is a good candidate for dividend investing.
DHT's Dividend Yield is rather good when compared to the industry average which is at 6.60. DHT pays more dividend than 86.27% of the companies in the same industry.
DHT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 9.95%

5.2 History

On average, the dividend of DHT grows each year by 70.23%, which is quite nice.
DHT has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of DHT decreased recently.
Dividend Growth(5Y)70.23%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

DHT pays out 96.69% of its income as dividend. This is not a sustainable payout ratio.
DHT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP96.69%
EPS Next 2Y22.23%
EPS Next 3Y25.53%

DHT HOLDINGS INC

NYSE:DHT (1/15/2025, 9:48:08 AM)

11.13

-0.05 (-0.45%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)02-05 2025-02-05/amc
Inst Owners62.71%
Inst Owner Change-0.59%
Ins Owners1.06%
Ins Owner ChangeN/A
Market Cap1.80B
Analysts82.67
Price Target13.49 (21.2%)
Short Float %4.49%
Short Ratio3.6
Dividend
Industry RankSector Rank
Dividend Yield 9.95%
Dividend Growth(5Y)70.23%
DP96.69%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.11%
Min EPS beat(2)-3.14%
Max EPS beat(2)7.36%
EPS beat(4)1
Avg EPS beat(4)-0.49%
Min EPS beat(4)-3.95%
Max EPS beat(4)7.36%
EPS beat(8)2
Avg EPS beat(8)-1.2%
EPS beat(12)6
Avg EPS beat(12)71.09%
EPS beat(16)8
Avg EPS beat(16)54.98%
Revenue beat(2)1
Avg Revenue beat(2)1.02%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)2.84%
Revenue beat(4)1
Avg Revenue beat(4)-2.07%
Min Revenue beat(4)-8.45%
Max Revenue beat(4)2.84%
Revenue beat(8)2
Avg Revenue beat(8)3.87%
Revenue beat(12)6
Avg Revenue beat(12)29.66%
Revenue beat(16)10
Avg Revenue beat(16)28.67%
PT rev (1m)-5.85%
PT rev (3m)-8.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-53.85%
EPS NY rev (1m)-0.11%
EPS NY rev (3m)-18.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-33.93%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-2.61%
Valuation
Industry RankSector Rank
PE 11.13
Fwd PE 7.52
P/S 3.08
P/FCF 9.51
P/OCF 6.53
P/B 1.74
P/tB 1.75
EV/EBITDA 6.97
EPS(TTM)1
EY8.98%
EPS(NY)1.48
Fwd EY13.29%
FCF(TTM)1.17
FCFY10.51%
OCF(TTM)1.7
OCFY15.31%
SpS3.62
BVpS6.38
TBVpS6.38
PEG (NY)6.2
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.97%
ROE 15.7%
ROCE 13.88%
ROIC 10.96%
ROICexc 11.57%
ROICexgc 11.59%
OM 33.26%
PM (TTM) 27.72%
GM 55.55%
FCFM 32.36%
ROA(3y)4.73%
ROA(5y)6.93%
ROE(3y)6.79%
ROE(5y)10.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-13.13%
ROICexcg growth 5Y64.01%
ROICexc growth 3Y-13.16%
ROICexc growth 5Y63.98%
OM growth 3Y-9.97%
OM growth 5Y45.73%
PM growth 3Y-9.27%
PM growth 5YN/A
GM growth 3Y-5.61%
GM growth 5Y9.15%
F-Score6
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 2.16
Debt/EBITDA 1.17
Cap/Depr 76.51%
Cap/Sales 14.78%
Interest Coverage 6.02
Cash Conversion 89.65%
Profit Quality 116.75%
Current Ratio 2.41
Quick Ratio 2.41
Altman-Z 3.17
F-Score6
WACC8.94%
ROIC/WACC1.23
Cap/Depr(3y)87.24%
Cap/Depr(5y)66.01%
Cap/Sales(3y)28.04%
Cap/Sales(5y)19.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.04%
EPS 3Y-16.82%
EPS 5YN/A
EPS Q2Q%15.79%
EPS Next Y1.79%
EPS Next 2Y22.23%
EPS Next 3Y25.53%
EPS Next 5Y25.22%
Revenue 1Y (TTM)-0.23%
Revenue growth 3Y-6.74%
Revenue growth 5Y8.32%
Sales Q2Q%3.99%
Revenue Next Year1.68%
Revenue Next 2Y3.34%
Revenue Next 3Y6.05%
Revenue Next 5Y12.57%
EBIT growth 1Y-10.27%
EBIT growth 3Y-16.03%
EBIT growth 5Y57.86%
EBIT Next Year56.2%
EBIT Next 3Y28.09%
EBIT Next 5Y30.28%
FCF growth 1Y470.71%
FCF growth 3Y-37.43%
FCF growth 5YN/A
OCF growth 1Y387.04%
OCF growth 3Y-22.01%
OCF growth 5Y36.02%